Dr. David Razmik Alajajian, MD

Dr. Alajajian practices at Apla Health - Michael Gottlieb Health Center in Los Angeles, California.

Dr. Alajajian's NPI, 1215354337, was assigned on March 26, 2014. Dr. Alajajian graduated from New York Medical College in 2014. Dr. Alajajian holds California license A147528.

Dr. Alajajian's primary practice is Apla Health - Michael Gottlieb Health Center, at 1625 N Schrader Blvd, Los Angeles, CA 90028 in Los Angeles County. The practice phone is (323) 988-1400.

Dr. Alajajian's primary practice is Apla Health - Michael Gottlieb Health Center in Los Angeles, California. The medical group on file is APLA Health. Dmand AI also links Dr. Alajajian to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alajajian practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Alajajian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Alajajian is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Alajajian's licenses on file in 2 states: California and New York.

Dmand AI lists anxiety, asthma, chronic diabetes, chronic hypertension, chronic obstructive pulmonary disease (COPD), coronary artery disease, fluid and electrolyte imbalances and high cholesterol among the conditions Dr. Alajajian treats.

CMS data shows 248 Medicare services from Dr. Alajajian across 4 procedure codes in 2024, all of them office visits, for 54 Medicare patients. Medicare paid $24,798 for them. Every service was in an office.

CMS counts 54 Medicare patients who saw Dr. Alajajian in 2024. The largest group is 65 to 74, with 23 patients. 65% of them have high cholesterol, and 63% have high blood pressure. 35% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alajajian's median patient age at 45, with 20% women.

In 2024, Dr. Alajajian wrote 496 Medicare Part D claims for 37 patients. 73% of them were for generic drugs. CMS names the drug for 216 of them, across 14 drugs with 11 or more claims each, at $277,754 in total drug cost. In 2023, CMS named 194 claims across 14 drugs.

Dmand AI links 2 papers to Dr. Alajajian in 2012.

CMS Open Payments shows 1,112 general payments to Dr. Alajajian from 53 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. ViiV Healthcare Company paid the most, $5,074. It also lists 8 research payments totaling $1,042 in 2017.

Dr. Alajajian graduated from New York Medical College in 2014.

Dr. Alajajian is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.